Featured Research

from universities, journals, and other organizations

Obesity drug failing patients due to lack of education about side-effects

Date:
May 8, 2014
Source:
University of Surrey
Summary:
Patients who gained weight 18 months after taking Orlistat attributed their weight-loss failure either to the side effects which have prevented them from sticking to the medication or felt that the medication simply had not worked. Orlistat is currently the only prescribed drug for obesity and functions by reducing the amount of fat absorbed from food eaten.

A new study, published today in the Journal of Health Psychology, found that patients who gained weight 18 months after taking Orlistat attributed their weight-loss failure either to the side effects which have prevented them from sticking to the medication or felt that the medication simply had not worked.

Related Articles


The team from the University of Surrey also found that participants described a series of barriers to weight loss including psychological and physical health issues, relationships and the make-up of their bodies. They also described a number of alternative methods of weight loss that had also failed, and the failure of Orlistat was included within this idea of permanent and ongoing failure.

Orlistat is currently the only prescribed drug for obesity and functions by reducing the amount of fat absorbed from food eaten.

"Our results have significant implications for GPs and how they should communicate with the patients about this drug," said lead author Dr Amelia Hollywood from the University of Surrey.

"GPs can improve patient support while taking Orlistat. At present, the so called "side effects" of Orlistat are seen as unpleasant and intrusive. If health professionals can highlight that such "side effects" are actually the consequences of eating high-fat foods while taking the drug, it could help ensure a change in diets.

"In addition, by alerting patients to these consequences and emphasising the need for dietary change, patients may be in a better position to make an informed judgement as to whether they wish to be prescribed this medication. GPs may likewise be able to make a more informed decision as to whether the medication should be prescribed, which could have cost implications for the NHS by reducing the waste of medications."


Story Source:

The above story is based on materials provided by University of Surrey. Note: Materials may be edited for content and length.


Journal Reference:

  1. Amelia Hollywood, Jane Ogden. Gaining weight after taking orlistat: A qualitative study of patients at 18-months follow-up. Journal of Health Psychology, May 2014 DOI: 10.1177/1359105314532153

Cite This Page:

University of Surrey. "Obesity drug failing patients due to lack of education about side-effects." ScienceDaily. ScienceDaily, 8 May 2014. <www.sciencedaily.com/releases/2014/05/140508095409.htm>.
University of Surrey. (2014, May 8). Obesity drug failing patients due to lack of education about side-effects. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2014/05/140508095409.htm
University of Surrey. "Obesity drug failing patients due to lack of education about side-effects." ScienceDaily. www.sciencedaily.com/releases/2014/05/140508095409.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins